HL7 Board of Directors

You can also view the Executive Bios or Past HL7 Board Chairs.

The HL7 Executive Committee consists of the officers and the non-voting members of the board.

HL7 Board of Directors

Officers

Board Chair
Julia Skapik MD, MPH
National Association of Community Health Centers
Term ends Dec 2025
Board Secretary
Virginia Lorenzi FHL7
New York-Presbyterian Hospital
Term ends Dec 2024
Board Treasurer
John Hatem FHL7, MBA, MSc
Term ends Dec 2025
Chair Emeritus
W. Edward Hammond PhD, FHL7
Duke Clinical & Translational Science Institute
Vice Chair
Andrew Truscott FHL7
Accenture
Term ends Dec 2024

 

Directors

Affiliate Director
Fernando Campos FHL7
HL7 Argentina
Term ends Dec 2025
Affiliate Director
Giorgio Cangioli
HL7 Italy
Term ends Dec 2025
Affiliate Director
Ron Parker FHL7
HL7 Canada
Term ends Dec 2024
Affiliate Director
Line Saele MSc
HL7 Norway
Term ends Dec 2024
Appointed
Judy Gichoya MD
Term ends Dec 2025
Appointed
Danielle Leighton MLIS
Term ends Dec 2024
Appointed
Janet Marchibroda
Friends of HL7
Term ends Dec 2024
Director at Large
Lenel James FHL7, MBA
Blue Cross Blue Shield Association
Term ends Dec 2024
Director at Large
Josh Mandel MD
SMART Health IT
Term ends Dec 2025
Director at Large
Marjorie Rallins
Regenstrief Institute, Inc.
Term ends Dec 2025
Director at Large
Ken Rubin FHL7
University of Utah Health Care
Term ends Dec 2024
TSC Chair
Jean Duteau FHL7
Duteau Design Inc
Term ends Dec 2024

 

Non-Voting Members of the HL7 Board

Chief Executive Officer
Charles Jaffe MD, PhD, FHL7
Health Level Seven International
Chief Standards Development Officer
Daniel Vreeman DPT, FHL7
Health Level Seven International
Executive Administrative Director
Karen Van Hentenryck
Health Level Seven International
Deputy Chief Standards Implementation Officer
Diego Kaminker FHL7
Health Level Seven International
Chief Standards Implementation Officer
Viet Nguyen MD
Health Level Seven International